Stay updated on Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.5.0 was added and v3.4.3 was removed.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page's revision tag was updated from v3.4.2 to v3.4.3, indicating an updated version of the content.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page now shows Revision: v3.4.2 and the older notices including the government funding lapse notice and Revision: v3.4.1 have been removed.SummaryDifference0.5%

- Check44 days agoChange DetectedAdded a government funding notice about potential delays and site status, and bumped the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check51 days agoChange DetectedAdded 'Show glossary' and updated the study results section to display 'Results First Posted' (replacing the 'Estimated' variant), along with 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', and updated the No FEAR Act data labeling and the site revision to v3.4.0.SummaryDifference0.4%

- Check65 days agoChange DetectedAdded a Revision: v3.3.4 and removed Revision: v3.3.3. This appears to be a metadata/version update with no impact on the study details or user actions.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page.